How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?

Ghosh, Priyanka; Raney, Sam G; Luke, Markham C

Ghosh, Priyanka; Raney, Sam G; Luke, Markham C.

Affiliation

Ghosh P; Office of Research and Standards, Office of Generic Drugs, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. Electronic address: Priyanka.Ghosh@fda.hhs.gov.
Raney SG; Office of Research and Standards, Office of Generic Drugs, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
Luke MC; Office of Research and Standards, Office of Generic Drugs, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Dermatol Clin ; 40(3): 279-287, 2022 Jul.

Article in En | MEDLINE | ID: mdl-35750411

Subject(s)

Drugs, Generic; Skin; Drugs, Generic/therapeutic use; Humans; Prospective Studies; Therapeutic Equivalency; United States; United States Food and Drug Administration

Key words

Dermatologic; Generics; Locally applied; Skin diseases; Topical

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin / Drugs, Generic Type of study: Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Dermatol Clin Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google